Cash on Hand for Agilent Technologies (A)
According to Agilent Technologies's latest reported financial statements, the company's latest reported cash and short-term investments is $1.76B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingCash on HandSwitch metric
Latest period
$1.76B
YoY change
+34.6%
5Y CAGR
+4.4%
Peak year (2011)
$3.53B
Latest annual
$1.79B
Cash on Hand history chart for Agilent Technologies (A) from 1998 to 2025
Cash on Hand history table for Agilent Technologies (A) from 1998 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $1.79B | +34.6% | ||
| 2024 | $1.33B | -16.4% | ||
| 2023 | $1.59B | +51.0% | ||
| 2022 | $1.05B | -33.1% | ||
| 2021 | $1.57B | +9.3% | ||
| 2020 | $1.44B | +4.3% | ||
| 2019 | $1.38B | -38.5% | ||
| 2018 | $2.25B | -16.1% | ||
| 2017 | $2.68B | +17.0% | ||
| 2016 | $2.29B | +14.3% | ||
| 2015 | $2.00B | -9.7% | ||
| 2014 | $2.22B | -17.1% | ||
| 2013 | $2.67B | +13.8% | ||
| 2012 | $2.35B | -33.3% | ||
| 2011 | $3.53B | +33.1% | ||
| 2010 | $2.65B | +6.3% | ||
| 2009 | $2.49B | +74.5% | ||
| 2008 | $1.43B | -21.7% | ||
| 2007 | $1.83B | -19.3% | ||
| 2006 | $2.26B | +0.5% | ||
| 2005 | $2.25B | -2.8% | ||
| 2004 | $2.31B | +44.1% | ||
| 2003 | $1.61B | -12.9% | ||
| 2002 | $1.84B | +57.6% | ||
| 2001 | $1.17B | +17.5% | ||
| 2000 | $996.00M | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — |
Cash on Hand values are taken from Agilent Technologies's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Agilent Technologies (A) most recent annual cash and short-term investments stands at $1.79B (2025) – surged 34.6% year-over-year.
Over 2020–2025 (5 years), Agilent Technologies cash and short-term investments expanded at a +4.4% compound annual rate, with the latest reading among the more recent periods of the dataset.
Agilent Technologies cash and short-term investments plunged from $3.53B in 2011 to $1.79B in 2025, a 49.3% drawdown.
2011 marks the peak cash and short-term investments at $3.53B, with the historical low of $0 recorded in 1998.
Among 8 Healthcare peers, Agilent Technologies (A) ranks 9th; the peer median for cash and short-term investments is $11.85B.
Agilent Technologies Cash on Hand by Year
Agilent Technologies Cash on Hand 2025: $1.79B
Agilent Technologies cash and short-term investments in 2025 was $1.79B, surged 34.6% from 2024.
Agilent Technologies Cash on Hand 2024: $1.33B
Agilent Technologies cash and short-term investments in 2024 was $1.33B, declined 16.4% below 2023.
Agilent Technologies Cash on Hand 2023: $1.59B
Agilent Technologies cash and short-term investments in 2023 was $1.59B, surged 51.0% from 2022.
Agilent Technologies Cash on Hand 2022: $1.05B
Agilent Technologies cash and short-term investments in 2022 was $1.05B, plunged 33.1% below 2021.
Agilent Technologies Cash on Hand 2021: $1.57B
Agilent Technologies cash and short-term investments in 2021 was $1.57B.
See more financial history for Agilent Technologies (A).
Sector peers — Cash on Hand
Companies in the same sector as Agilent Technologies, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Agilent Technologies's cash and short-term investments?
- Latest reported cash and short-term investments for Agilent Technologies (A) is $1.76B (period ending January 31, 2026).
How has Agilent Technologies cash and short-term investments changed year-over-year?
- Agilent Technologies (A) cash and short-term investments changed +34.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Agilent Technologies cash and short-term investments?
- Agilent Technologies (A) cash and short-term investments compound annual growth rate is +4.4% over the most recent 5 years available.
When did Agilent Technologies cash and short-term investments hit its highest annual value?
- Agilent Technologies cash and short-term investments reached its highest annual value of $3.53B in 2011.
What was Agilent Technologies cash and short-term investments in 2024?
- Agilent Technologies (A) cash and short-term investments in 2024 was $1.33B.
What was Agilent Technologies cash and short-term investments in 2025?
- Agilent Technologies (A) cash and short-term investments in 2025 was $1.79B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
A Overview
Company profile, financial tools, and key metrics
A Revenue Counter
Earns $224.03 every second. See per minute, hour, and day.
A Earnings Counter
Earns $40.91 per second net profit. See per minute, hour, and day.
A Economic Scale
Exceeds Maldives's GDP. Compare with world economies.
A What If Invested
What if you had invested $1,000? See historical returns from any date.
A How It Makes Money
Discover visual breakdown of $7.07B in revenue — where it comes from and where it goes.
A Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
A Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
A Daily Price Character
Balanced · 51.2% historical win rate (green days). Streaks & record days.
A Buybacks
1.29% TTM buyback yield. Shareholder yield & SBC comparison.
A Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
A Dividend Profile
Yield: 0.90%. Safety: 6/8. See full history.
A Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
A Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.